DB18185InvestigationalProtein Based Therapies
ATI-1013 is a fully human nicotine-specific monoclonal antibody.
- Also known as
- Fully human nicotine-specific monoclonal antibody
- Code names
- ATI-1013
Resolves to
Compound
What you can answer from here — as of October 23, 2025
Which companies are running trials of ATI-1013, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account